Big Drug Company Gilead Accused of Blocking Hydroxychloroqhine Use for Covid
Why? Allegedly because Hydroxychloroquine is off patent, therefore cheap, and would be competition for brand new, still patent protected, and super profitable drugs.
(From The American Thinker)
Notably in the U.S., a third of the FDA’s budget comes from pharmaceutical user fees, and according to the NIH’s website, eight out of 55 members of the panel responsible for COVID-19 treatment guidelines are currently affiliated with Gilead. These government ties to Gilead more than triple when you include panel members with past associations.
This article was originally posted here: https://www.ac2news.com/2020/09/big-drug-company-gilead-accused-of-blocking-hydroxychloroqhine-use-for-covid/.